Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of Bimatoprost SR in Open-angle Glaucoma or Ocular Hypertension
NCT02247804Phase 3Completed
- Sponsor
- Allergan
- Start
- Dec 2014
- Primary completion
- Feb 2018
- Modality
- Orthosteric Ligands
- Countries
- 14
01
Overview
A Phase 3 trial of bimatoprost in open-angle glaucoma (OAG), ocular hypertension, sponsored by Allergan. Started Dec 2014; status: completed.
02
Drugs
bimatoprost
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on NCT02247804.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02247804.